PiVOT CRO employees are 100% first dose and 96% fully vaccinated

We believe vaccinations are vital to ending this pandemic. Given that we are in the clinical trial industry, we understand the stringent processes the COVID-19 vaccines available today have gone through to establish that they are both safe and effective before being awarded Emergency Use Authorization (EUA) status by regulators. While vaccinates may not completely prevent infections, they greatly reduce the risk of severe COVID-19, hospitalization, and death to the vaccinated.

To this end, all 28 PiVOT employees have received their first dose with only one employee still waiting for the 2^nd dose. Employees have availed of vaccinations through their respective LGUs and through the vaccines that the company provided. We encourage everyone to get vaccinated!